Skip to main content
lexblog.com/lib/Q45JBNEEviewrecordjson
{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "FDA LDT Rule Begins Enforcement Discretion Phaseout, But Some Discretion Remains",
    "url": "https://www.lexblog.com/2024/05/21/fda-ldt-rule-begins-enforcement-discretion-phaseout-but-some-discretion-remains/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-Q45JBNEE",
        "url": "https://www.lexblog.com/lib/Q45JBNEE/"
    },
    "datePublished": "2024-05-21T11:30:26-04:00",
    "dateModified": "2024-05-21T08:31:22-04:00",
    "author": {
        "@type": "Person",
        "name": "Rebecca Jones McKnight, Kevin Madagan, Sarah Thompson Schick, Akosua Tuffuor"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Reed Smith LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Health Industry Washington Watch",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "https://www.healthindustrywashingtonwatch.com/?p=26302",
    "sourceStability": "may-move"
}